"Hyperbilirubinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
| Descriptor ID |
D006932
|
| MeSH Number(s) |
C23.550.429
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperbilirubinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperbilirubinemia".
This graph shows the total number of publications written about "Hyperbilirubinemia" by people in this website by year, and whether "Hyperbilirubinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperbilirubinemia" by people in Profiles.
-
Elsaie AL, Taleb M, Nicosia A, Zangaladze A, Pease ME, Newton K, Schutzman DL. Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia. J Perinatol. 2020 10; 40(10):1513-1517.
-
Schutzman DL, Bhutani VK, Castillo Cuadrado ME, Lamola AA, Frantz I, Obregon E, Wong RJ. A multi-center evaluation of a device for measurement of bilirubin binding capacity in neonates: the effects of gestational age, Intralipid exposure and illness severity. J Perinatol. 2019 06; 39(6):883-888.
-
Cairo SB, Osak AH, Berkelhamer SK, McLaughlin C, Rothstein DH. Direct hyperbilirubinemia in newborns with gastroschisis. Pediatr Surg Int. 2019 Mar; 35(3):293-301.
-
Palatnik A, Mele L, Landon MB, Reddy UM, Ramin SM, Carpenter MW, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Sciscione A, Catalano P, Saade GR, Caritis SN, Sorokin Y. Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes. Am J Obstet Gynecol. 2015 Oct; 213(4):560.e1-8.
-
Moyer LB, Goyal NK, Meinzen-Derr J, Ward LP, Rust CL, Wexelblatt SL, Greenberg JM. Factors associated with readmission in late-preterm infants: a matched case-control study. Hosp Pediatr. 2014 Sep; 4(5):298-304.
-
Hopkins LO, Feyssa E, Parsikia A, Khanmoradi K, Zaki R, Campos S, Araya V, Tran H, Ortiz J. Tc-99m-BrIDA hepatobiliary (HIDA) scan has a low sensitivity for detecting biliary complications after orthotopic liver transplantation in patients with hyperbilirubinemia. Ann Nucl Med. 2011 Dec; 25(10):762-7.
-
Schutzman DL, Sekhon R, Hundalani S. Hour-specific bilirubin nomogram in infants with ABO incompatibility and direct Coombs-positive results. Arch Pediatr Adolesc Med. 2010 Dec; 164(12):1158-64.
-
Meropol NJ, Rustum YM, Petrelli NJ, Rodriguez-Bigas M, Frank C, Ho DH, Kurowski M, Creaven PJ. A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer. Cancer Chemother Pharmacol. 1996; 37(6):581-6.